Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Fitbit and app aim to boost activity in cancer survivors

NCT ID NCT06840028

Symptom relief Sponsor: The University of Tennessee, Knoxville Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether personalized exercise plans delivered through a Fitbit and a smartphone app can help cancer survivors become more physically active. Researchers will track steps, weight, quality of life, and emotional well-being in 160 adult survivors who have finished active cancer treatment. The goal is to see if this mobile health approach improves health outcomes and daily life.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 160 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2025

Expected to finish

Apr 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Participant must be at least 18 years of age * Participant was previously diagnosed with stage 0-III cancer * Participant have had one or more of the cancers of interest (e.g., breast, lung) * Participant completed active cancer treatment at least three months prior to enrollment, with the exception of continued maintenance immunotherapy or endocrine therapy * Participant possess basic English communication capability * Participant do not participate in other health promotion programs * Participant is an Android or Apple smartphone owner * Participant is willing to participate in mHealth-delivered programs * Participant is willing to consent and be randomized * Participant has no contraindications to PA participation Exclusion Criteria: * Participant is currently undergoing chemotherapy or radiation as primary cancer treatment * Having any contraindications that might interfere with PA engagement, such as a medical condition and pacemaker implant * Plan to relocate or travel for \>two weeks during the study period; * Presence of distant metastasis * Planning or preparing for surgery as primary treatment or as a reconstruction procedure in the next 3 months * Have a stage 4 cancer diagnosis * Participant is already engaging in ≥75 min/week of vigorous-intensity PA, ≥150 min/week of moderate-intensity PA, or an equivalent combination of both over the last 3 months * An unstable mental condition that would prevent following study protocols * Reporting a Physical Activity Readiness Questionnaire (PAR-Q) score that indicates PA may be unsafe * Being a prisoner, pregnant, or planning to become pregnant

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cancer Chronic Disease Motor Activity neoplasm Sedentary Behavior

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cancer survivors Cancer survivorship Chronic disease Physical activity Physical activity in adults Physical inactivity

Contacts and locations

Locations

  • University of Tennessee Medical Center

    Knoxville, Tennessee, 37920, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.